Lazard Asset Management’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$48K Buy
10,857
+3,262
+43% +$14.4K ﹤0.01% 2015
2025
Q1
$35K Buy
+7,595
New +$35K ﹤0.01% 2054